123 related articles for article (PubMed ID: 2450240)
41. Improvement of pentobarbital-induced heart failure by MCI-154, a novel and potent cardiotonic agent, in the dog heart-lung preparation.
Satoh K; Nunoki K; Goto T; Hosono M; Hashimoto H; Sato Y; Taira N
Jpn J Pharmacol; 1988 Jun; 47(2):189-95. PubMed ID: 3199595
[TBL] [Abstract][Full Text] [Related]
42. Sensitization of dog and guinea pig heart myofilaments to Ca2+ activation and the inotropic effect of pimobendan: comparison with milrinone.
Fujino K; Sperelakis N; Solaro RJ
Circ Res; 1988 Nov; 63(5):911-22. PubMed ID: 2846200
[TBL] [Abstract][Full Text] [Related]
43. Cardiovascular effects of NSP-804 and NSP-805, novel cardiotonic agents with vasodilator properties.
Mochizuki N; Uchida S; Miyata H
J Cardiovasc Pharmacol; 1993 Jun; 21(6):983-95. PubMed ID: 7687727
[TBL] [Abstract][Full Text] [Related]
44. Comparison of cardiovascular effects of a new calcium channel blocker AH-1058 with those of verapamil assessed in blood-perfused canine heart preparations.
Takahara A; Sugiyama A; Dohmoto H; Yoshimoto R; Hashimoto K
J Cardiovasc Pharmacol; 2000 May; 35(5):741-8. PubMed ID: 10813376
[TBL] [Abstract][Full Text] [Related]
45. Increase in Ca++ sensitivity of the contractile system by MCI-154, a novel cardiotonic agent, in chemically skinned fibers from the guinea pig papillary muscles.
Kitada Y; Narimatsu A; Matsumura N; Endo M
J Pharmacol Exp Ther; 1987 Nov; 243(2):633-8. PubMed ID: 3500301
[TBL] [Abstract][Full Text] [Related]
46. Cardiotonic and coronary vasodilator responses to milrinone, forskolin, and analog P87-7692 in the anesthetized dog.
Lebedinsky Y; Nordstrom ST; Aschoff SE; Kapples JF; O'Malley GJ; Kosley RW; Fielding S; Hubbard JW
J Cardiovasc Pharmacol; 1992 May; 19(5):779-89. PubMed ID: 1381777
[TBL] [Abstract][Full Text] [Related]
47. Changes in membrane potentials and currents of ventricular cells of the guinea pig heart by a new cardiotonic drug, MCI-154.
Katayama S; Narimatsu A; Suzuki R; Iijima T; Taira N
Jpn J Pharmacol; 1987 Aug; 44(4):481-8. PubMed ID: 3682412
[TBL] [Abstract][Full Text] [Related]
48. Cardiotonic and coronary vasodilatatory effects of amrinone in the canine heart-lung preparation with a support dog as compared with those of dobutamine.
Takeda K; Matsui K; Nakazawa M; Nakahara H; Imai H; Imai S
Jpn J Pharmacol; 1986 Mar; 40(3):381-8. PubMed ID: 3012165
[TBL] [Abstract][Full Text] [Related]
49. T-1583 and forskolin are similar in their cardiac effects and dissimilar in their vascular effects.
Hosono M; Satoh K; Taira N
Cardiovasc Drugs Ther; 1988 Jul; 2(2):245-53. PubMed ID: 2908722
[TBL] [Abstract][Full Text] [Related]
50. The effects of levosimendan on myocardial function in ropivacaine toxicity in isolated guinea pig heart preparations.
Stehr SN; Christ T; Rasche B; Rasche S; Wettwer E; Deussen A; Ravens U; Koch T; Hübler M
Anesth Analg; 2007 Sep; 105(3):641-7. PubMed ID: 17717217
[TBL] [Abstract][Full Text] [Related]
51. Simultaneous assessment of the effects of trimetazidine on the myocardium and coronary vasculature of the dog.
Yanagisawa T; Satoh K; Taira N
Arch Int Pharmacodyn Ther; 1979 Feb; 237(2):316-29. PubMed ID: 485693
[TBL] [Abstract][Full Text] [Related]
52. Cardiovascular pharmacology of the vasodilator-cardiotonic agent, 349U85.
Steffen RP; Wastila WB
J Cardiovasc Pharmacol; 1992 Oct; 20(4):579-89. PubMed ID: 1280714
[TBL] [Abstract][Full Text] [Related]
53. Comparative effects of inotropic agents on coronary and systemic hemodynamics of conscious dogs: actions of milrinone, dopamine, ouabain and MCI-154.
Al-Wathiqui MH; Shimshak TM; Brooks HL; Preuss KC; Wynsen JC; Gross GJ; Warltier DC
Pharmacology; 1988; 36(4):217-27. PubMed ID: 3380877
[TBL] [Abstract][Full Text] [Related]
54. Pharmacology of RG W-2938: a cardiotonic agent with vasodilator activity.
Barrett JA; Woltmann RF; Swillo RS; Kasiewski C; Faith WC; Campbell HF; Perrone MH
J Cardiovasc Pharmacol; 1990 Oct; 16(4):537-45. PubMed ID: 1706794
[TBL] [Abstract][Full Text] [Related]
55. Comparison of cardiovascular effects of a novel class Ic antiarrhythmic agent, NIK-244, with those of flecainide in isolated canine heart preparations cross-circulated with a donor dog.
Sugiyama A; Motomura S; Hashimoto K
Jpn J Pharmacol; 1991 May; 56(1):1-12. PubMed ID: 1908917
[TBL] [Abstract][Full Text] [Related]
56. Lacidipine, a new long-acting dihydropyridine calcium antagonist, has high vascular selectivity against all intracardiac variables.
Motomura S; Wu ZJ; Hashimoto K
Heart Vessels; 1993; 8(1):16-22. PubMed ID: 8454559
[TBL] [Abstract][Full Text] [Related]
57. Cardiovascular effects of optical isomers of cibenzoline, assessed in the canine isolated, blood-perfused papillary muscle and sinoatrial node preparations.
Takehana S; Sugiyama A; Hashimoto K
J Cardiovasc Pharmacol; 1999 Nov; 34(5):660-5. PubMed ID: 10547081
[TBL] [Abstract][Full Text] [Related]
58. Positive chronotropic and inotropic effects of pimobendan (UD-CG 115 BS) in isolated, cross-circulated canine heart preparations.
Furukawa Y; Akahane K; Ogiwara Y; Haniuda M; Chiba S
Arch Int Pharmacodyn Ther; 1989; 300():159-73. PubMed ID: 2575887
[TBL] [Abstract][Full Text] [Related]
59. Cardiac effects of amiloride in the dog.
Yamashita S; Motomura S; Taira N
J Cardiovasc Pharmacol; 1981; 3(4):704-15. PubMed ID: 6167801
[TBL] [Abstract][Full Text] [Related]
60. Cardiovascular actions of the dihydropyridine calcium antagonist nimodipine in the dog.
Satoh K; Kawada M; Wada Y; Taira N
Arzneimittelforschung; 1984; 34(5):563-8. PubMed ID: 6540573
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
